Immunology is a discipline of medical and biological research that studies the immune system. The immune system defends us against infection in a variety of ways. Diseases such as autoimmunity, allergies, and cancer can occur when the human immune system is not operating properly. Autoimmune diseases occur when the immune system attacks the body that itâ€™s meant to protect. People suffering from autoimmune diseases have a defect that makes their immune system unable to distinguish ‘self’ from â€˜non-selfâ€™ or ‘foreign’ molecules. Immunology provides a wide variety of laboratory tests for the detection of autoimmune diseases.
Recent product approvals by regulatory agencies is expected to drive the market growth over the forecast period.
The approval of new drugs and the trends of improvements in clinical efficiencies will bode well for the global immunology industry. For instance, the Food and Drug Administration (FDA) granted AbbVie permission to use â€˜SKYRIZI’ in 2019. The medication was developed to treat moderate to severe plaque psoriasis. This medication was designed to treat adults with psoriasis who had been prescribed or were receiving treatment.
Request Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/4594
Global Immunology Market â€“ Regional Analysis
Globally North America has the largest share in immunology drug market because of the availability of better reimbursement policies, high potential to invest a huge amount of money in the development of immunology drugs, and due to the advancement of technologies. Moreover, because of the easy accessibility to immunology medications and the high affordability of therapy, Europe is the second largest region in terms of market value. Increase in awareness, rising economy, increasing government initiatives, and large patient pool in Asia-Pacific regions also demonstrate a high growth in global immunology market.
Global Immunology Market: Restraint
High costs of immunology drug, adverse effects associated with these drugs, and lack of awareness are the major factors that can hinder the growth of the global immunology market. For instance, according to data reported by the New York Times from SSR health, a research firm, the price of Humira (a prescription injection used to treat rheumatoid arthritis and other conditions) has gone up from about US$ 19,000 a year (in 2012) to more than US$ 38,000 a year (in 2019) per patient.
Major players operating in the global immunology market include AbbVie Inc., Janssen Global Services, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Amgen Inc., Pfizer Inc., Novartis, Astellas, Bristol-Myers Squibb Company, Merck Sharp & Dohme Corp., UCB SA, and Allergan plc.
Buy Now This Research Report: https://www.coherentmarketinsights.com/insight/buy-now/4594
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027